Stage IB1 to IIA cervical cancer surgery with possible radiation
Part of Cancer, Women’s health & pregnancy clinical trials.
This Phase 3 trial studies how best to treat intermediate-risk cervical cancer using radical surgery, with or without additional radiation after surgery. It may help find which approach lowers the chance the cancer comes back for patients with certain tumor risk features.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed invasive cervical cancer found on biopsy
- Your cancer stage is IB1, IB2, or IIA (not earlier or later)
- Your cancer type is squamous cell or HPV-related adenocarcinoma
- Your tumor has “intermediate-risk” features (often based on size and specific tissue findings)
- Scans and final surgical tests show no suspicious pelvic lymph nodes or spread to distant areas
- You can safely have major surgery (and are well enough to do daily activities, ECOG 0–1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares standard radiation to radiation plus chemotherapy after surgery for early-stage cervical cancer. It aims to lower the chance the cancer comes back in patients considered higher risk based on their surgical pathology.
This Phase 3 trial tests whether adding chemotherapy after surgery helps people with locally advanced cervical cancer, especially when prior treatment didn’t fully match standard guidelines. It looks at whether this “adjuvant” chemotherapy improves outcomes after neoadjuvant chemotherapy and an extensive hysterectomy.
This study tests whether adding immunotherapy to chemotherapy, then giving chemotherapy together with radiation, works better for advanced cervical cancer. It aims to improve cancer control and help people live longer, without major safety issues.
This trial studies whether removing lymph nodes during surgery helps people with stage IIICr cervical cancer. It looks at outcomes and may help guide better treatment for lymph node spread.
This trial tests if giving chemotherapy plus an immunotherapy drug before surgery can help shrink tumors and improve outcomes for patients with stage IB2 cervical cancer that has not been treated yet. It might be an option if you have a specific type of cervical cancer that shows a certain protein (PD-L1) on your tumor cells.
This trial tests a type of radiation that adapts to your body changes during treatment for cervical cancer. It aims to improve accuracy and reduce side effects.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.